XML 29 R11.htm IDEA: XBRL DOCUMENT v3.24.1
Cash, Cash Equivalents and Investments
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Cash, Cash Equivalents and Investments

Note 4: Cash, Cash Equivalents and Investments

 

The following tables categorize the fair values of cash, cash equivalents, short-term investments and long-term investments measured at fair value on a recurring basis on our balance sheets (in thousands):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Cash and cash equivalents:

 

 

 

 

 

 

Cash

 

$

1,521

 

 

$

3,986

 

Money market funds

 

 

4,285

 

 

 

10,988

 

Repurchase agreements

 

 

 

 

 

9,000

 

Government and agency notes

 

 

14,946

 

 

 

20,605

 

Total cash and cash equivalents

 

$

20,752

 

 

$

44,579

 

 

 

 

 

 

 

Short-term investments:

 

 

 

 

 

 

Certificates of deposit

 

$

729

 

 

$

5,390

 

Municipal notes

 

 

 

 

 

506

 

Corporate notes

 

 

 

 

 

12,411

 

Government and agency notes

 

 

53,578

 

 

 

27,295

 

Total short-term investments

 

$

54,307

 

 

$

45,602

 

 

 

 

 

 

 

Long-term investments

 

 

 

 

 

 

Certificates of deposit

 

$

 

 

$

712

 

Government and agency notes

 

 

 

 

 

2,866

 

Total long-term investments

 

$

 

 

$

3,578

 

 

The investments are classified as available-for-sale securities. As of December 31, 2023, the weighted average remaining contractual maturities of available-for-sale securities was approximately 2 months. At December 31, 2023 and 2022, the unrealized gain (loss) activity related to the Company’s available-for-sale securities is included in the Company’s accumulated other comprehensive loss. There were no significant realized gains or losses recognized on the sale or maturity of available-for-sale securities for the years ended December 31, 2023 and 2022 and as a result, the Company did not reclassify any amounts out of accumulated other comprehensive loss. Based on the Company’s review of its available-for-sale securities, the Company has a limited number of available-for-sale securities in insignificant loss positions as of December 31, 2023. No other-than-temporary impairments on these securities were recognized for the years ended as of December 31, 2023 and 2022.

For available-for-sale debt securities in an unrealized loss position, the Company first assesses whether it intends to sell, or it is more likely than not that it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value and recognized in interest and other income, net in the statement of operations and comprehensive loss. If neither criteria is met, the Company evaluates whether the decline in fair value is related to credit-related factors or other factors. In making this assessment, management considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security, among other factors. Credit-related impairment losses, limited by the amount that the fair value is less than the amortized cost basis, are recorded through an allowance for credit losses in interest and other income, net.

Any unrealized losses from declines in fair value below the amortized cost basis as a result of non-credit factors are recognized in accumulated other comprehensive loss, net of tax as a separate component of stockholders’ equity, along with unrealized gains. Realized gains and losses and declines in fair value, if any, on available-for-sale securities are included in interest and other income, net in the statement of operations and comprehensive loss.

For purposes of identifying and measuring credit-related impairments, the Company’s policy is to exclude applicable accrued interest from both the fair value and amortized cost basis of the related security. The Company has elected to write-off uncollectible accrued interest receivable balances in a timely manner, which is defined by the Company as when interest due becomes 90 days delinquent. The accrued interest write-off will be recorded by reversing interest income. Accrued interest receivable is recorded in other current assets on the balance sheets.

 

The following table summarizes the available-for-sale securities (in thousands):

 

 

 

 

Fair Value Measurements at December 31, 2023

 

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair Value

 

Money market funds

 

$

4,285

 

 

$

 

 

$

 

 

$

4,285

 

Certificates of Deposit

 

 

735

 

 

 

 

 

 

(6

)

 

 

729

 

Government and agency notes

 

 

68,528

 

 

 

13

 

 

 

(17

)

 

 

68,524

 

Total cash equivalents and investments

 

$

73,548

 

 

$

13

 

 

$

(23

)

 

$

73,538

 

 

 

 

 

 

 

 

 

 

 

 

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents (original maturities within 90 days)

 

 

 

 

 

 

 

 

 

 

$

19,231

 

Short-term investments (maturities within 1 year)

 

 

 

 

 

 

 

 

 

 

 

54,307

 

Total cash equivalents and investments

 

 

 

 

 

 

 

 

 

 

$

73,538

 

 

 

 

Fair Value Measurements at December 31, 2022

 

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair Value

 

Money market funds

 

$

10,988

 

 

$

 

 

$

 

 

$

10,988

 

Certificates of Deposit

 

 

6,237

 

 

 

1

 

 

 

(136

)

 

 

6,102

 

Repurchase Agreements

 

 

9,000

 

 

 

 

 

 

 

 

 

9,000

 

Corporate notes

 

 

12,575

 

 

 

 

 

 

(164

)

 

 

12,411

 

Government and agency notes

 

 

51,020

 

 

 

4

 

 

 

(258

)

 

 

50,766

 

Municipal notes

 

 

510

 

 

 

 

 

 

(4

)

 

 

506

 

Total cash equivalents and investments

 

$

90,330

 

 

$

5

 

 

$

(562

)

 

$

89,773

 

 

 

 

 

 

 

 

 

 

 

 

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents (original maturities within 90 days)

 

 

 

 

 

 

 

 

 

 

$

40,593

 

Short-term investments (maturities within 1 year)

 

 

 

 

 

 

 

 

 

 

 

45,602

 

Long-term investments (maturities beyond 1 year)

 

 

 

 

 

 

 

 

 

 

 

3,578

 

Total cash equivalents and investments

 

 

 

 

 

 

 

 

 

 

$

89,773

 


The table below summarizes the unrealized losses of the Company's investments in debt securities measured at fair value as of December 31, 2023 (in thousands):

 

 

Less than twelve months

 

 

Twelve months or greater

 

 

Total

 

 

 

Fair value

 

 

Gross unrealized loss

 

 

Fair value

 

 

Gross unrealized loss

 

 

Fair value

 

 

Gross unrealized loss

 

Certificates of deposit

 

$

 

 

$

 

 

$

729

 

 

$

(6

)

 

$

729

 

 

$

(6

)

Government and agency notes

 

 

3,966

 

 

 

 

 

 

2,975

 

 

 

(17

)

 

 

6,941

 

 

 

(17

)

Total cash equivalents and investments

 

$

3,966

 

 

$

 

 

$

3,704

 

 

$

(23

)

 

$

7,670

 

 

$

(23

)

There were no transfers between Levels 1, 2 or 3 for the period presented.

The table below summarizes the contractual maturities of the Company's investments in debt securities measured at fair value as of December 31, 2023 (in thousands):

 

 

Maturities by Period

 

 

 

Total

 

 

Less Than 1 Year

 

 

1-5 Years

 

 

6-10 Years

 

 

More Than 10 Years

 

Fair value of debt securities

 

$

54,307

 

 

$

54,307

 

 

$

 

 

$

 

 

$